Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas.

Chen, Jing; Liu, Yibing; Xu, Ke; Ren, Fei; Li, Bowen; Sun, Hong

Chen, Jing; Liu, Yibing; Xu, Ke; Ren, Fei; Li, Bowen; Sun, Hong.

Afiliação

Chen J; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
Liu Y; The Third Bethune Clinical Medical College, Jilin University, Changchun, China.
Xu K; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
Ren F; The Second Bethune Clinical Medical College, Jilin University, Changchun, China.
Li B; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
Sun H; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.

Front Oncol ; 12: 999012, 2022.

Article em En | MEDLINE | ID: mdl-36226064

Palavras-chave

SEER database; clinicopathologic feature; gastroenteropancreatic neuroendocrine carcinomas; nomogram; overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google